Authors:
TENERO DM
MARTIN DE
ILSON BE
BOYLE DA
BOIKE SC
CARR AM
LUNDBERG DE
JORKASKY DK
Citation: Dm. Tenero et al., EFFECT OF RANITIDINE ON THE PHARMACOKINETICS OF ORALLY-ADMINISTERED EPROSARTAN, AN ANGIOTENSIN-II ANTAGONIST, IN HEALTHY MALE-VOLUNTEERS, The Annals of pharmacotherapy, 32(3), 1998, pp. 304-308
Authors:
TENERO DM
MARTIN DE
MILLER AK
ILSON B
BOIKE SC
ZARIFFA N
JORKASKY DK
Citation: Dm. Tenero et al., EFFECT OF AGE AND GENDER ON THE PHARMACOKINETICS OF EPROSARTAN, British journal of clinical pharmacology, 46(3), 1998, pp. 267-270
Citation: De. Wilson et al., USE OF TOPICAL CORTICOSTEROID PRETREATMENT TO REDUCE THE INCIDENCE AND SEVERITY OF SKIN REACTIONS ASSOCIATED WITH TESTOSTERONE TRANSDERMAL THERAPY, Clinical therapeutics, 20(2), 1998, pp. 299-306
Citation: Be. Ilson et al., THE EFFECTS OF EPROSARTAN, AN ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONIST, ON URIC-ACID EXCRETION IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, Journal of clinical pharmacology, 38(5), 1998, pp. 437-441
Authors:
MARTIN DE
CHAPELSKY MC
ILSON B
TENERO D
BOIKE SC
ZARIFFA N
JORKASKY DK
Citation: De. Martin et al., PHARMACOKINETICS AND PROTEIN FINDING OF EPROSARTAN IN HEALTHY-VOLUNTEERS AND IN PATIENTS WITH VARYING DEGREES OF RENAL IMPAIRMENT, Journal of clinical pharmacology, 38(2), 1998, pp. 129-137
Authors:
CHAPELSKY MC
MARTIN DE
TENERO DM
ILSON BE
BOIKE SC
ETHEREDGE R
JORKASKY DK
Citation: Mc. Chapelsky et al., A DOSE PROPORTIONALITY STUDY OF EPROSARTAN IN HEALTHY MALE-VOLUNTEERS, Journal of clinical pharmacology, 38(1), 1998, pp. 34-39
Authors:
WILSON DE
MEIKLE AW
BOIKE SC
FAIRLESS AJ
ETHEREDGE RC
JORKASKY DK
Citation: De. Wilson et al., BIOEQUIVALENCE ASSESSMENT OF A SINGLE 5 MG DAY TESTOSTERONE TRANSDERMAL SYSTEM VERSUS 2 2.5 MG/DAY SYSTEMS IN HYPOGONADAL MEN/, Journal of clinical pharmacology, 38(1), 1998, pp. 54-59
Authors:
ILSON BE
BOIKE SC
MARTIN DE
FREED MI
ZARIFFA N
JORKASKY DK
Citation: Be. Ilson et al., A DOSE-RESPONSE STUDY TO ASSESS THE RENAL HEMODYNAMIC, VASCULAR, AND HORMONAL EFFECTS OF EPROSARTAN, AN ANGIOTENSIN-II AT(1)-RECEPTOR ANTAGONIST, IN SODIUM-REPLETE HEALTHY-MEN, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 471-481
Citation: Sc. Boike et al., CARDIOVASCULAR EFFECTS OF IV-GRANISETRON AT 2 ADMINISTRATION RATES AND OF ONDANSETRON IN HEALTHY-ADULTS, American journal of health-system pharmacy, 54(10), 1997, pp. 1172-1176
Authors:
MARTIN DE
TOMPSON D
BOIKE SC
TENERO D
ILSON B
CITERONE D
JORKASKY DK
Citation: De. Martin et al., LACK OF EFFECT OF EPROSARTAN ON THE SINGLE-DOSE PHARMACOKINETICS OF ORALLY-ADMINISTERED DIGOXIN IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 43(6), 1997, pp. 661-664
Citation: Lj. Smith et al., INTRAVENOUS PRANLUKAST (ULTAIR(TM)) INHIBITS LTD(4)-INDUCED BRONCHOCONSTRICTION IN PATIENTS WITH ASTHMA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1341-1341
Authors:
STREK ME
SEDY J
SOLWAY J
JORKASKY DK
JONES B
BOIKE SC
Citation: Me. Strek et al., PRANLUKAST (ULTAIR(TM)) INHIBITS COLD AIR-INDUCED BRONCHOCONSTRICTIONIN PATIENTS WITH ASTHMA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1342-1342
Authors:
EVERITT DE
BOIKE SC
PILTZSEYMOUR JR
VANCOEVORDEN R
AUDET P
ZARIFFA N
JORKASKY D
Citation: De. Everitt et al., EFFECT OF INTRAVENOUS FENOLDOPAM ON INTRAOCULAR-PRESSURE IN OCULAR HYPERTENSION, Journal of clinical pharmacology, 37(4), 1997, pp. 312-320
Authors:
MARTIN DE
DECHERNEY GS
ILSON BE
JONES BA
BOIKE SC
FREED MI
JORKASKY DK
Citation: De. Martin et al., EPROSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, DOES NOT AFFECT THE PHARMACODYNAMICS OF GLYBURIDE IN PATIENTS WITH TYPE-II DIABETES-MELLITUS, Journal of clinical pharmacology, 37(2), 1997, pp. 155-159
Authors:
KAZIERAD DJ
MARTIN DE
BLUM RA
TENERO DM
ILSON B
BOIKE SC
ETHEREDGE R
JORKASKY DK
Citation: Dj. Kazierad et al., EFFECT OF FLUCONAZOLE ON THE PHARMACOKINETICS OF EPROSARTAN AND LOSARTAN IN HEALTHY MALE-VOLUNTEERS, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 417-425
Authors:
KAZIERAD DJ
MARTIN DE
TENERO D
BOIKE SC
ILSON B
FREED MI
ETHEREDGE R
JORKASKY DK
Citation: Dj. Kazierad et al., FLUCONAZOLE(F) SIGNIFICANTLY ALTERS THE PHARMACOKINETICS (PK) OF LOSARTAN(L) BUT NOT EPROSARTAN(E), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 35-35
Authors:
RUGGIERI EV
BUGELSKI PJ
KAPLAN JM
EVERITT D
LIPANI J
JORKASKY DK
BOIKE SC
DECLEMENT F
MOORE FD
HERZYK DJ
Citation: Ev. Ruggieri et al., RELATIONSHIPS BETWEEN ANTIBODIES AGAINST HUMAN SOLUBLE COMPLEMENT RECEPTOR-1 (HSCR1) FROM VARIOUS SPECIES, Journal of clinical immunology, 16(2), 1996, pp. 97-106
Authors:
BROCKS DR
MEIKLE AW
BOIKE SC
MAZER NA
ZARIFFA N
AUDET PR
JORKASKY DK
Citation: Dr. Brocks et al., PHARMACOKINETICS OF TESTOSTERONE IN HYPOGONADAL MEN AFTER TRANSDERMALDELIVERY - INFLUENCE OF DOSE, Journal of clinical pharmacology, 36(8), 1996, pp. 732-739
Authors:
BOIKE SC
PUE M
AUDET PR
FREED MI
FAIRLESS A
ILSON BE
ZARIFFA N
JORKASKY DK
Citation: Sc. Boike et al., PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH CHRONIC HEPATIC-DISEASE, Journal of clinical pharmacology, 34(12), 1994, pp. 1199-1207
Authors:
BOIKE SC
PUE MA
FREED MI
AUDET PR
FAIRLESS A
ILSON BE
ZARIFFA N
JORKASKY DK
Citation: Sc. Boike et al., PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 418-426